| BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma F Puls, A Niblett, G Marland, CLL Gaston, H Douis, DC Mangham, ... The American journal of surgical pathology 38 (10), 1307-1318, 2014 | 203 | 2014 |
| Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone? CL Gaston, R Bhumbra, M Watanuki, AT Abudu, SR Carter, LM Jeys, ... The Journal of Bone & Joint Surgery British Volume 93 (12), 1665-1669, 2011 | 110 | 2011 |
| Aneurysmal bone cysts: do simple treatments work? KIA Reddy, F Sinnaeve, CL Gaston, RJ Grimer, SR Carter Clinical Orthopaedics and Related Research® 472, 1901-1910, 2014 | 108 | 2014 |
| Denosumab treatment of inoperable or locally advanced giant cell tumor of bone–multicenter analysis outside clinical trial P Rutkowski, L Gaston, A Borkowska, S Stacchiotti, H Gelderblom, ... European Journal of Surgical Oncology 44 (9), 1384-1390, 2018 | 105 | 2018 |
| Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone CL Gaston, RJ Grimer, M Parry, S Stacchiotti, AP Dei Tos, H Gelderblom, ... Clinical Sarcoma Research 6, 1-6, 2016 | 104 | 2016 |
| Proximal tibia reconstruction after bone tumor resection: are survivorship and outcomes of endoprosthetic replacement and osteoarticular allograft similar? JI Albergo, CL Gaston, LA Aponte-Tinao, MA Ayerza, DL Muscolo, ... Clinical Orthopaedics and Related Research® 475, 676-682, 2017 | 92 | 2017 |
| Conventional primary central chondrosarcoma of the pelvis: prognostic factors and outcome of surgical treatment in 162 patients MPA Bus, DA Campanacci, JI Albergo, A Leithner, MAJ van de Sande, ... JBJS 100 (4), 316-325, 2018 | 81 | 2018 |
| Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins? KIA Reddy, H Wafa, CL Gaston, RJ Grimer, AT Abudu, LM Jeys, SR Carter, ... The bone & joint journal 97 (1), 115-120, 2015 | 80 | 2015 |
| A novel system for the surgical staging of primary high-grade osteosarcoma: the Birmingham classification LM Jeys, CJ Thorne, M Parry, CLL Gaston, VP Sumathi, JR Grimer Clinical Orthopaedics and Related Research® 475, 842-850, 2017 | 76 | 2017 |
| Ewing’s sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response JI Albergo, CL Gaston, M Laitinen, A Darbyshire, LM Jeys, V Sumathi, ... The bone & joint journal 98 (8), 1138-1144, 2016 | 69 | 2016 |
| 18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different LL Gaston, C Di Bella, J Slavin, RJ Hicks, PFM Choong Skeletal radiology 40, 1007-1015, 2011 | 67 | 2011 |
| Osteonecrosis of the jaw and rebound hypercalcemia in young people treated with denosumab for giant cell tumor of bone S Uday, CL Gaston, L Rogers, M Parry, J Joffe, J Pearson, D Sutton, ... The Journal of Clinical Endocrinology & Metabolism 103 (2), 596-603, 2018 | 66 | 2018 |
| Osteosarcoma of the pelvis MC Parry, M Laitinen, J Albergo, L Jeys, S Carter, CL Gaston, V Sumathi, ... The bone & joint journal 98 (4), 555-563, 2016 | 59 | 2016 |
| The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma T Nakamura, R Grimer, C Gaston, M Francis, J Charman, P Graunt, ... European journal of cancer 49 (2), 377-385, 2013 | 58 | 2013 |
| The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone T Nakamura, RJ Grimer, CL Gaston, M Watanuki, A Sudo, L Jeys The bone & joint journal 95 (3), 411-418, 2013 | 54 | 2013 |
| Does osteofibrous dysplasia progress to adamantinoma and how should they be treated? DW Scholfield, Z Sadozai, C Ghali, V Sumathi, H Douis, L Gaston, ... The bone & joint journal 99 (3), 409-416, 2017 | 46 | 2017 |
| Hypotensive epidural anesthesia reduces blood loss in pelvic and sacral bone tumor resections AK Freeman, CJ Thorne, LC Gaston, R Shellard, T Neal, MC Parry, ... Clinical Orthopaedics and Related Research® 475 (3), 634-640, 2017 | 37 | 2017 |
| What is the morbidity of a non-invasive growing prosthesis? MM Gilg, CL Gaston, MC Parry, L Jeys, A Abudu, RM Tillman, SR Carter, ... The Bone & Joint Journal 98 (12), 1697-1703, 2016 | 35 | 2016 |
| Risk analysis factors for local recurrence in Ewing’s sarcoma: when should adjuvant radiotherapy be administered? JI Albergo, CLL Gaston, MC Parry, MK Laitinen, LM Jeys, RM Tillman, ... The bone & joint journal 100 (2), 247-255, 2018 | 32 | 2018 |
| Silver-coated (Agluna®) tumour prostheses can be a protective factor against infection in high risk failure patients MC Parry, MK Laitinen, JI Albergo, CL Gaston, JD Stevenson, RJ Grimer, ... European Journal of Surgical Oncology 45 (4), 704-710, 2019 | 30 | 2019 |
